Optometry News

Attempts to curtail prior authorizations for patients insured by Medicare Advantage plans have failed in back-to-back legislative sessions in 2019 and 2021, but a new bill has some experts hopeful that the third time is a charm.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Yuna Rapoport, MD, MPH, of Manhattan Eye, discusses light heat therapy for dry eye disease and lotilaner for Demodex blepharitis.

Retinal ganglion cell layer thickness was significantly reduced in patients with severe COVID-19, which indicates an affinity for nerve cells, according to research published in the Open Journal of Ophthalmology.

Delayed diagnosis of congenital optic disc abnormalities increases the risk for complications and may affect visual prognosis, according to a study published in the Open Journal of Ophthalmology.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Amy Zhang, MD, of Kellog Eye Center in Northville, Michigan, explains why ophthalmologists should prioritize healthy ergonomics in the OR.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Anita Campbell, MD, of Stiles Eyecare Excellence, discusses canaloplasty and trabeculotomy outcomes with the Omni surgical system.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Carole C. Foos, CPA, of OJM Group discusses saving and investing pearls for ophthalmologists.

The retinal image-based, deep-learning cardiac BioAge model accurately stratified individuals by traditional cardiovascular disease risk biomarkers, with leukocyte telomere length inversely related to BioAge score, researchers reported.

Clearside Biomedical announced the completion of the final participant visit in its ODYSSEY phase 2b clinical trial of CLS-AX, an axitinib injectable suspension for neovascular age-related macular degeneration.

The European Commission granted marketing authorization to Akantior for the treatment of Acanthamoeba keratitis, according to a press release from Avanzanite Bioscience.